TITLE:
Association between Dengue Fever and Pregnancy at the Sourô Sanou University Hospital Center in Bobo-Dioulasso, Burkina Faso, Based on 58 Cases: Clinical, Biological, and Prognostic Aspects
AUTHORS:
Zénabou Boussini, Semon Paulin Kam, Waaviel Carine Linda Some, Wend-Data Arlette Yamwemba, Jean De La Croix Millogo, Alihonou Serges Eric Togbé, Evelyne Komboigo, Der Adolphe Somé
KEYWORDS:
Dengue, Pregnant Women, Complications, Fever, Bobo-Dioulasso
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.16 No.2,
February
12,
2026
ABSTRACT: Objective: The objective of this study was to describe the clinical, biological, and prognostic aspects of dengue and pregnancy in pregnant women hospitalized in a university hospital in Burkina Faso from August 1, 2023, to February 7, 2024. Methodology: This was a descriptive cohort study conducted from August 1, 2023, to February 7, 2024. It involved 58 pregnant women admitted to the obstetrics department of the Sourô Sanou University Hospital Center who had a confirmed diagnosis of dengue fever. The variables investigated were the clinical, biological, and prognostic aspects of this association. Data were collected through direct individual interviews supplemented by a literature review and recorded on a written questionnaire. The analysis was performed using Epi-Info software version 7.0.9.7. Results: The frequency of dengue fever and pregnancy was 2.08% of all pregnant women admitted to the emergency department. The average age of the patients was 26.8 years and the average gestational age was 2.6 months. Patients who were in the third trimester of their pregnancy accounted for 38%. The main complications were hemorrhage, hepatic cytolysis, intrauterine fetal death, and prematurity. Perinatal mortality was 13.8% and maternal mortality was 1.7%. Conclusion: Maternal and fetal complications are common in cases of dengue fever and pregnancy. When faced with any fever in a pregnant woman in our context, healthcare providers should systematically consider the diagnosis of dengue until proven otherwise. Infected women should then receive multidisciplinary follow-up until delivery.